[ad_1]
Shares of Procter & Gamble Co. were knocked lower in early Tuesday trading, after the consumer packaged-goods company reported fiscal fourth-quarter profit that beat expectations but also a surprise dip in sales.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...